CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Auditor change
- 8-K Event Material agreement · New debt or obligation
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 2,500 shares (grant or award)
- 4 Grant or award VP and Chief Compliance Office acquired 4,000 shares (grant or award)
- 4 Grant or award Sr VP/Chief Commercial Officer acquired 5,000 shares (grant or award)
- 4 Grant or award SVP and Chief Development Off. acquired 25,000 shares (grant or award)
- 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
Page 22 of 52 · 1,039 filings